Sign in to view content

Faricimab in Neovascular Age-Related Macular Degeneration: Year 2 Efficacy, Safety, and Durability Results From the Phase 3 TENAYA and LUCERNE Trials

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2022

Related

Higher-Order Optical Coherence Tomography Fluid Burden Assessment: Analysis From the OSPREY Trial
Justis P. Ehlers, MD, FASRS
Annual Meeting Talks
2019
Are There Safety Concerns With Bevacizumab for ROP
Robert L. Avery, MD
Updates from the Field
2017
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss
Jennifer K. Sun, MD
Updates from the Field
2019

Category: wet AMD

See more